FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2
  • Home
  • About
  • Projects
    • P1 Lymph-Transplant
    • P2 Modulators of LA
    • N1 Ocular GvHD
    • N2 ABCB5 & Pterygium
    • P4 Ocular Melanoma
    • P5 Myeloid Cells
    • P6 Microglia in AMD
    • P8 Uveitis
    • C1 Eye Imaging
    • C2 Management
    • Publication highlights
  • Team
    • Executive Board
    • Research Groups
    • Central Projects
    • Associated projects
    • Alumni
  • Links
  • Events
    • Guest lectures
    • Retreats
    • Symposium
  • News
✕

Prof. Hamrah – scientist of Cell Molecular & Developmental Biology, Immunology and Neuroscience

Prof. Pedram Hamrah from the Tufts University School of Medicine in Boston, USA visited the University Clinic of Cologne in May 2019. He had meetings with the FOR2240 scientists Dr. Notara, Dr. Clahsen, Dr. Hos and Dr. Bock and they discussed topics including “the role of limbal stem cells in corneal neovascularisation”and “Tyrosinase is a novel endogenous inhibitor of lymphangiogenesis”.
On 16th of July, during the meeting of the European Vision Institute – SPECIAL INTEREST FOCUS GROUP which was hosted by the University Hospital of Cologne, Prof. Hamrah held a lecture followed by a discussion on the topic: Corneal nerve imaging and quantification in pain, dry eye and inflammation and their pathophysiologic relevance.
Prof. Pedram Hamrah is Professor of Ophthalmology and a scientist of Cell Molecular & Developmental Biology, Immunology and Neuroscience. His research interests include dendritic cells found in the eye, with special emphasis on their role in corneal transplantation, neurotrophic keratitis, and herpetic keratitis.

Related posts

January 7, 2023

Dr. Sarah Barbara Zwingelberg, is awarded Belmonte Fellowship for research on the neurobiology of the ocular surface


Read more
December 15, 2022

Leonhard Klein-Preis for Prof. Matthaei


Read more
November 22, 2022

4th Shanghai-Cologne Scientific Symposium


Read more

News

  • Rare eye diseases: Eight million euros for research: Funding for four years
  • Dr. Sarah Barbara Zwingelberg, is awarded Belmonte Fellowship for research on the neurobiology of the ocular surface
  • Experimental Glaucoma Research Group awarded and funded
  • Leonhard Klein-Preis for Prof. Matthaei
  • 4th Shanghai-Cologne Scientific Symposium

More information

  • Publication highlights
  • Jobs
  • Contact
  • Impressum
  • Datenschutz

Newest publications

Supplemental Anti Vegf A-Therapy Prevents Rebound…(2020)


Bevacizumab Induces Upregulation of Keratin 3 and VEGFA in Human…(2020)


Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional…(2020)


Contact

Esther Engel
Management Office
DFG Research Unit FOR2240
Department of Ophthalmology
University of Cologne
Kerpener Str. 62
50937 Cologne, Germany

www.for2240.de

Tel. +49 (0)221 478 32845
Fax. +49 (0)221 478 5094
esther.engel@uk-koeln.de

Partnerlogos

© 2021 FOR2240 | Online Marketing von Resulted Lübeck